Depixus
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3-5 Impasse Reille, Paris, Ile-de-France...Phone Number
+33 972482089Website
www.depixus.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Depixus
Depixus is developing a set of technologies to enable the fast, accurate, and inexpensive extraction of genetic and epigenetic information from single molecules of DNA and RNA. Validation of many of Depixus' technologies is at an advanced stage and commercial development is well underway. The company has strong backing from a group of very experienced angel investors, several of whom are veterans of the sequencing industry.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Depixus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Depixus had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Depixus has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Depixus launches new products
Depixus, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Depixus has recently received funding, and reach out quickly before it becomes old news!
Check out if Depixus is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Depixus
Earning: See what the market has to say on Depixus recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Depixus as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Depixus is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Depixus is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Depixus.
Depixus financials insights
Gather financial insights about Depixus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$35.4M
Depixus Tech Stack
A closer look at the technologies used by Depixus
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Product Marketing, Events, Engineering, Sales, Bioengineering, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Depixus News & Media
New Study Demonstrates Power of Depixus’ Scalable Single Molecule Interactomics Platform to Accelerate RNA-Targeted Drug Development
PARIS--(BUSINESS WIRE)--New study highlights how Depixus’ scalable single molecule technology can provide detailed mechanistic insights into RNA-ligand binding.Depixus wins SLAS2024 Ignite Award for MAGNA™ technology
PARIS--(BUSINESS WIRE)--Interactomics pioneer Depixus has won the prestigious SLAS 2024 Ignite Award for their novel MAGNA™ technology.Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology
PARIS--(BUSINESS WIRE)--Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the role of Chief Commercial Officer.Depixus Launches Technology Access Program With First MAGNA One™ Instrument Placement
PARIS--(BUSINESS WIRE)--Interactomics pioneer Depixus has launched its game-changing MAGNA™ technology access program with the first MAGNA One™ beta prototype instrument.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Depixus
Sign Up For FreeTo access detailed company insights
Depixus is developing a set of technologies to enable the fast, accurate, and inexpensive extraction of genetic and epigenetic information from single molecules of DNA and RNA. Validation of many of Depixus' technologies is at an advanced stage and commercial development is well underway. The company has strong backing from a group of very experien... Read More
